AptarGroup (ATR) FX & Other Adjustments — Quarterly & Annual

Screener

Discontinued — last reported Q1 '21

FX & Other Adjustments at other companies

AshlandASH

——

Baxter InternationalBAX

——

Segments

By segment

Pharma-$4.36M—

Beauty-$690K—

Closures-$284K—

Other financials

Income statement

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

Market cap$8.69B-4.7%

Enterprise value$9.9B-2.2%

P/E22.5×-0.8×

P/S2.3×-0.3×

Profitability

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: AptarGroup’s 10-Q, filed April 30, 2021. Open the filing →

Filed: Apr 30, 2021, 10:35 AM EDT
Fiscal quarter: Q1 FY2021
Calendar quarter: Q1 2021
Accession: 0000896622-21-000025